stem
cell
research
establish
new
humanembryon
stem
cell
hesc
line
develop
cultur
condit
mainten
establish
cell
line
effici
stabli
fundament
area
research
requir
develop
detail
investig
addit
recent
studi
examin
clinic
applic
stem
cell
cell
therapi
product
regen
medicin
highlight
import
secur
hesc
clinic
grade
qualiti
hovatta
tannenbaum
et
al
thu
sever
group
attempt
establish
hesc
line
remov
animalderiv
compon
cultur
condit
maintain
xenofre
condit
report
establish
new
hesc
line
success
cultur
xenofre
cultur
condit
publish
et
al
crook
et
al
ilic
et
al
tannenbaum
et
al
mani
effort
made
develop
appropri
stem
cell
cultur
protocol
use
hesc
clinic
applic
establish
cultur
freez
thaw
skottman
et
al
sinc
first
establish
hesc
thomsonet
al
hesc
cultur
condit
use
mous
deriv
fibroblast
mous
embryon
fibroblast
mef
sto
feeder
cell
howev
concern
remain
regard
potenti
risk
cell
line
contamin
unknown
compon
secret
anim
deriv
materi
therefor
studi
perform
overcom
challeng
soong
et
al
exampl
studi
examin
replac
mous
deriv
fibroblast
human
tissuederiv
feeder
cell
human
foreskin
fibroblast
fetal
muscl
fibroblast
richard
et
al
umbil
cord
deriv
mesenchym
stem
cell
ding
et
al
marrow
stromal
cell
havasi
et
al
placent
cell
park
et
al
addit
research
also
attempt
develop
extracellular
matrix
xenofre
medium
use
feederfre
condit
cultur
without
feeder
cell
wang
et
al
also
continu
effort
maintain
hesc
effici
stabli
establish
new
cell
line
develop
cultur
condit
human
amniot
fluid
cell
hafc
use
forprenat
genet
diagnosi
examin
possibl
fetal
abnorm
cell
easili
obtain
pregnant
women
second
midtrimest
amniocentesi
prusa
hengstschlag
although
studi
character
variou
type
cell
found
amniot
fluid
cell
amniot
fluid
shown
capabl
differenti
three
germ
layer
cell
thu
cell
potenti
applic
materi
studi
neuron
differenti
stem
cell
prusa
hengstschlag
kook
et
al
amniot
fluid
deriv
stem
cell
intermedi
characterist
hesc
adult
stem
cell
express
marker
express
bone
marrow
deriv
mesenchym
stem
cell
cell
also
express
marker
undifferenti
state
he
cell
includ
nanog
bajek
et
al
particular
repres
marker
undifferenti
hesc
shown
express
amniot
fluidderiv
stem
cell
prusa
et
al
moreov
hafc
shown
higher
reprogram
effici
establish
induc
pluripot
stem
cell
ipsc
somat
cell
galend
et
al
addit
studi
use
hafc
feeder
cell
kim
et
al
success
cultur
hesc
use
hafc
feeder
cell
instead
mous
deriv
fibroblast
commonli
use
report
also
describ
mainten
undifferenti
state
hesc
use
human
amniot
fluid
cellderiv
stem
cell
feeder
cell
without
addit
basic
fibroblast
growth
factor
bfgf
et
al
new
hesc
line
establish
use
amniot
fluidderiv
mesenchym
stem
cell
feeder
cell
soong
et
al
current
studi
examin
whether
clinic
gradehesc
could
cultur
xenofre
medium
without
anim
deriv
materi
cultur
condit
use
human
extracellular
matrix
hafc
feeder
cell
hesc
line
use
present
studi
aclin
grade
cell
line
establish
institut
reproduct
medicin
popul
medic
research
center
seoul
nation
univers
wicel
research
institut
use
control
human
amniot
fluid
cell
use
feeder
cell
maintain
undifferenti
state
hesc
hafc
store
frozen
vial
liquid
nitrogen
tank
thaw
flask
coat
cellstart
invitrogen
cell
cultur
medium
contain
dulbecco
modifi
eagl
medium
dmem
invitrogen
fetal
bovin
serum
fb
hyclon
use
incub
day
inactiv
hafc
cell
growth
suppress
treatment
mitomycin
c
sigma
h
cell
transfer
cellstartco
cultur
dish
densiti
clinic
grade
cell
line
establish
inxenofre
medium
use
human
foreskin
fibroblast
feeder
cell
use
control
cultur
use
hafc
feeder
cell
dmem
invitrogen
use
basic
medium
supplement
kosr
xenofre
invitrogen
ngml
bfgf
invitrogen
mm
ps
invitrogen
mm
neaa
invitrogen
mm
invitrogen
cell
subcultur
mechan
transfer
method
use
pasteur
pipett
week
mainten
test
maintain
mitomycin
ctreatedsto
atcc
feeder
kosr
ngml
bfgf
mm
ps
mm
neaa
mm
mercaptoethanol
sigma
day
subcultur
werewash
dpb
invitrogen
fix
paraformaldehyd
pfa
usb
ap
express
examin
stain
use
alkalin
phosphatas
diagnost
kit
sigma
accord
manufactur
instruct
medium
remov
hesc
day
ofsubcultur
cell
wash
dpb
fix
pfa
wash
dpb
contain
sigma
bovin
serum
albumin
bsa
sigma
ratio
incub
least
h
primari
antibodi
santa
cruz
millipor
millipor
millipor
dilut
bsa
triton
sigma
solut
ad
fix
cell
follow
incub
least
h
cell
wash
dpb
mix
secondari
antibodi
alexa
fluor
donkey
antimous
igg
molecular
probe
alexa
fluor
donkey
antimous
igg
molecular
probe
alexa
fluor
donkey
antirabbit
igg
dilut
molecular
probe
solut
contain
bsa
triton
use
primari
antibodi
cell
incub
dark
condit
room
temperatur
h
final
nuclei
stain
dapi
molecular
probe
cell
observ
fluoresc
microscop
rna
extract
hesc
use
rneasi
minikit
qiagen
accord
manufactur
instruct
revers
transcrib
cdna
use
mmlv
revers
transcriptas
invitrogen
subject
pcr
determin
express
marker
includ
nanog
sequenc
primer
use
studi
shown
tabl
cell
coloni
isol
hesc
use
pasteurpipett
transfer
microtub
wash
dpb
hesc
disassoci
singl
cell
treatment
accutas
invitrogen
centrifug
rpm
min
addit
pfa
fixat
room
temperatur
min
cell
centrifug
rpm
min
isol
cell
mix
primari
antibodi
target
dilut
solut
contain
bsa
triton
cell
incub
h
centrifug
rpm
min
similar
primari
antibodi
treatment
cell
treat
secondari
antibodi
alexa
fluor
donkey
antimous
igg
alexa
fluor
label
donkey
antirabbit
igg
dilut
incub
dark
condit
room
temperatur
h
centrifug
optim
volum
dpb
ad
cell
pellet
resuspend
cell
subject
analysi
use
flow
cytomet
facsaria
bd
bioscienc
hesc
cultur
use
hafc
feeder
cell
withoutanim
deriv
compon
flow
cytomet
use
determin
whether
biolegend
anim
deriv
compon
could
detect
sampl
prepar
describ
flow
cytometri
analysi
marker
undifferenti
cell
incub
primari
antibodi
target
follow
incub
conjug
antichicken
millipor
secondari
antibodi
cell
analyz
use
flow
cytomet
facscalibur
bd
scienc
cultur
passageswhil
maintain
undifferenti
state
use
hafc
feeder
cell
passag
cultur
hesc
maintain
properti
hafc
use
feeder
cell
fibroblast
type
shown
fig
cultur
use
establish
human
foreskin
fibroblast
establish
mef
adapt
well
hafc
without
complic
round
singl
layer
typic
hesc
coloni
observ
fig
c
studi
attempt
replac
materi
thatwer
gener
use
hesc
cultur
human
materi
order
minim
exposur
hesc
anim
deriv
compon
cultur
thu
hafc
use
feeder
cell
instead
mous
deriv
fibroblast
cultur
cultur
dish
coat
cellstart
human
extracellular
matrix
instead
gelatin
hesc
medium
replac
medium
contain
kosr
xenofre
xenofre
cultur
environ
abl
adapt
new
cultur
condit
character
cultur
onhafc
test
passag
ap
activ
determin
use
ap
stain
kit
data
indic
undifferenti
state
maintain
fig
addit
immunocytochemistri
icc
rtpcr
flow
cytometri
use
test
express
level
pluripot
marker
undifferenti
cell
express
level
cell
surfac
marker
includ
transcript
factor
determin
use
icc
stain
observ
fluoresc
microscop
posit
stain
detect
case
fig
addit
rtpcr
also
demonstr
express
pluripot
marker
hesc
includ
nanog
shown
fig
examin
express
marker
theundifferenti
state
express
level
quantit
analyz
use
flow
cytometri
cultur
either
hafc
human
foreskin
fibroblast
analyz
detect
marker
includ
fluoresc
stain
combin
flow
cytometri
differ
express
level
detect
two
experiment
group
posit
respons
fig
final
investig
contamin
cultur
flow
cytometri
analysi
use
specif
antibodi
order
examin
whether
anim
deriv
materi
present
use
describ
cell
cultur
condit
result
show
grown
hafc
contamin
fig
contrast
detect
cultur
sto
fig
current
use
research
protocol
medium
containingmous
deriv
fibroblast
fb
gener
use
cultur
hesc
research
purpos
cultur
condit
effici
maintain
undifferenti
state
hesc
suitabl
use
clinic
applic
owe
risk
infect
variou
virus
pathogen
feeder
cell
media
use
risk
contamin
unknown
compon
hovattta
mallon
et
al
therefor
research
attempt
reduc
use
anim
deriv
materi
focus
develop
new
xenofre
cultur
condit
complet
exclud
materi
exampl
human
pluripot
stem
cell
hpsc
success
cultur
use
human
deriv
feeder
cell
richard
et
al
kim
et
al
park
et
al
ding
et
al
havasi
et
al
soong
et
al
et
al
clinic
grade
hesc
line
establish
cultur
xenofre
environ
ilic
et
al
tannenbaum
et
al
studi
popular
product
commerci
widespread
use
villadiaz
et
al
present
studi
aim
determin
two
hesc
line
could
grow
maintain
undifferenti
state
new
cultur
condit
remov
anim
deriv
materi
hafc
use
feeder
cell
replac
mous
deriv
fibroblast
hafc
success
feeder
layer
cell
line
adapt
well
medium
contain
kosr
xenofre
rather
kosr
xenofre
cultur
condit
use
cultur
dish
coat
human
cellstart
rather
pigderiv
gelatin
use
experiment
group
show
distinct
morpholog
chang
compar
cultur
human
foreskin
fibroblast
control
character
pluripot
marker
also
show
cell
maintain
properti
hesc
although
examin
express
marker
undifferenti
state
studi
still
use
fb
hafc
cultur
expect
hesc
abl
cultur
improv
cultur
condit
fb
replac
human
serum
base
current
publish
literatur
mous
derivedfibroblast
materi
secret
fibroblast
anim
deriv
materi
fb
immunolog
risk
risk
infect
anim
virus
prion
difficult
qualit
assess
risk
due
presenc
unidentifi
materi
ilic
et
al
exampl
xenotransplant
materi
detect
hesc
cocultur
anim
deriv
fibroblast
medium
contain
anim
deriv
serum
compon
materi
known
caus
problem
includ
immun
reject
infect
later
transplant
martin
et
al
henc
current
studi
examin
whether
hesc
contamin
commonli
detect
condit
anim
deriv
feeder
cell
medium
contain
animalderiv
materi
use
flow
cytometri
analysi
antibodi
show
grown
hafc
free
infect
howev
even
human
deriv
feeder
cell
use
areplac
anim
deriv
materi
risk
clinic
applic
need
broadli
test
includ
basic
screen
diseas
viral
infect
donor
stacey
et
al
sever
factor
test
human
deriv
materi
cell
use
biolog
medicin
cobo
et
al
includ
human
immunodefici
viru
hiv
hepat
b
c
e
human
cytomegaloviru
hcmv
cell
leukemia
viru
htlv
herp
virus
herp
simplex
viru
epsteinbarr
viru
human
polyoma
viru
parvoviru
ttv
addit
essenti
check
infect
base
newli
discov
high
risk
infecti
diseas
includ
creutzfeldtjakob
diseas
nonvir
infecti
diseas
sever
acut
respiratori
syndrom
sar
studi
clinic
grade
hesc
reubinoff
teamreport
establish
clinic
grade
hesc
line
xenofre
gmp
grade
human
deriv
feeder
cell
research
team
establish
cultur
clinic
grade
hesc
xenofre
cultur
condit
use
human
deriv
feeder
cell
includ
umbil
cord
foreskin
fetal
muscl
cell
cultur
gmp
grade
clean
room
also
verifi
safeti
materi
use
cultur
qualiti
manag
experiment
step
addit
monitor
step
requir
verif
hesc
use
cell
therapi
product
futur
includ
tissu
use
feeder
cell
screen
embryo
donor
establish
hesc
cultur
freez
character
stem
cell
bank
establish
guidelin
ethic
system
limit
regul
experiment
method
detail
clinic
applic
provid
solid
foundat
clinic
grade
studi
tannenbaum
et
al
base
stem
cell
investig
intern
standard
guidelin
regul
develop
individu
countri
includ
safeti
test
qualiti
assur
basic
cell
cultur
hesc
cell
line
institut
condit
accord
variou
guidelin
clinic
stage
requir
hesc
approv
medic
product
recent
studi
hpsc
includ
hesc
focusedon
next
stage
clinic
applic
necessit
compat
cell
therapi
product
clinic
applic
final
goal
stem
cell
studi
therefor
addit
chang
effici
cultur
condit
must
establish
growth
hesc
reduc
anim
deriv
compon
replac
human
human
deriv
materi
basic
cell
cultur
environ
studi
also
conduct
xenofre
feederfre
environ
cultur
without
feeder
cell
addit
improv
cultur
condit
qualiti
manag
cultur
hesc
standard
procedur
includ
detect
microorgan
virus
anim
deriv
materi
identif
inappropri
harm
substanc
need
develop
standard
product
clinic
grade
hesc
next
preparatori
step
applic
hesc
cell
base
therapi
regen
medicin
